1. Introduction {#sec1-nutrients-09-01326}
===============

Diet composition is known to affect health. Evidence from randomized clinical trials suggests that an increased dietary protein content helps to increase weight loss and limit weight regain in overweight and obese individuals \[[@B1-nutrients-09-01326],[@B2-nutrients-09-01326]\], although observational studies do not always support a negative association between dietary protein content and prospective weight gain \[[@B3-nutrients-09-01326],[@B4-nutrients-09-01326]\]. In addition, the beneficial effects of increased protein consumption on blood pressure, HDL (high density lipoprotein) cholesterol, fasting insulin, and triglyceride concentrations have been reported in a meta-analysis of human intervention studies \[[@B1-nutrients-09-01326]\]. Much less is known about the importance of the sources from which these proteins are derived for these beneficial effects. A review on the effect of proteins from different sources on body composition concluded that the evidence for differences among protein sources is currently inconclusive \[[@B5-nutrients-09-01326]\]. In contrast, two large observational studies reported that long-term weight gain was associated with a higher intake of proteins from animal sources \[[@B3-nutrients-09-01326],[@B6-nutrients-09-01326]\]. Another review focusing on protein sources in relation to coronary heart disease and underlying risk factors did not reveal clear differences among protein sources \[[@B7-nutrients-09-01326]\]. On the other hand, the Nurses' Health Study suggested that consuming poultry, fish, low-fat dairy, or nuts instead of red meat would lower the risk of coronary heart disease and stroke \[[@B8-nutrients-09-01326],[@B9-nutrients-09-01326]\]. A review on the role of dietary proteins in blood pressure (BP) control concluded that there may be a small beneficial effect of protein on BP, especially for plant protein \[[@B10-nutrients-09-01326]\]. A higher animal protein intake was associated with a higher risk of type 2 diabetes in the EPIC-NL (European Prospective Investigation Into Cancer and Nutrition--Netherlands) study, whereas no association with plant protein intake was found \[[@B11-nutrients-09-01326]\].

Given the paucity and inconsistency of data on protein intake from various sources on body weight and cardiometabolic risk, we took the opportunity to conduct a secondary analysis of data from the randomized controlled DIOGenes trial, which investigated the role of dietary protein content and glycemic index (GI) on weight loss maintenance and cardiometabolic risk factors in overweight and obese families \[[@B12-nutrients-09-01326],[@B13-nutrients-09-01326]\]. We focused our analyses on protein sources from food groups that made an important contribution to the diet. In this exploratory secondary analysis, we therefore studied whether substituting animal protein for plant protein, or cereal-protein for non-cereal protein, or meat for other animal protein, would affect these parameters.

2. Materials and Methods {#sec2-nutrients-09-01326}
========================

Data were collected in the context of the DIOGenes randomized clinical trial that was executed in eight European countries between 2005 and 2009. The aim of the DIOGenes trial was to investigate the effect of diet composition on weight loss maintenance in families with one or both parents overweight or obese, with a focus on dietary protein content and glycemic index. The design and main results of the trial have been published previously \[[@B12-nutrients-09-01326],[@B13-nutrients-09-01326]\]. The study was conducted according to the Declaration of Helsinki, and was approved by the Medical Ethical Committee of the University of Copenhagen (KF01-267787 IHE 4-1-2.0091 dd. 23-03-2006) and the local ethical committees in the respective countries. All of the subjects gave written informed consent before starting their participation in the study.

2.1. Subjects {#sec2dot1-nutrients-09-01326}
-------------

All of the adult participants of the DIOGenes trial who had completed the six-month dietary intervention phase after the successful completion of an initial eight-week weight loss phase (i.e., attained weight loss ≥8%) were included. Details on recruitment and exclusion criteria have been provided in a previous paper \[[@B13-nutrients-09-01326]\]. Subjects were healthy, had a BMI (Body Mass Index) ≥ 27 kg/m^2^, were below 65 years of age and had at least one child aged 5--18 years living in their household.

2.2. Study Design {#sec2dot2-nutrients-09-01326}
-----------------

After inclusion into the study, subjects started an eight-week low-calorie diet (LCD) period. If ≥8% of initial body weight was lost after eight weeks, families were randomized to one of five *ad libitum* maintenance diets for 26 weeks. 773 adult participants were randomized. The five diet groups were a high protein/high GI group, a low protein/high GI group, a high protein/low GI group, low protein/low GI group and a group that followed the recommended diet in each of the countries. The low protein groups were advised a diet with a protein content between 10 and 15% of energy intake (% energy), the high protein groups a protein content between 23 and 28 energy %. The targeted difference in dietary GI between the low and high GI groups was 15 glycemic-index units. All of the diets advised a fat intake of \<30 energy %. The aim of this 26-week intervention period was to maintain body weight loss. Dietary instructions on the *ad libitum* diets were provided by trained dietitians, as described previously \[[@B14-nutrients-09-01326]\]. In addition, two of the centres (Copenhagen and Maastricht) provided the foods free of charge to the participants from laboratory supermarkets \[[@B13-nutrients-09-01326]\].

2.3. Procedures {#sec2dot3-nutrients-09-01326}
---------------

Before the start of the weight loss phase (baseline), subjects filled in a three-day food diary (two week days and one weekend day). Subsequently, they came for a clinical investigation day (CID1 = baseline) to the research centers. Measurements on a CID included anthropometric and blood pressure measurements, a fasting blood sample and an oral glucose tolerance test with blood collection. These clinical investigations were repeated at the end of the eight-week weight loss (WL) period (CID2), and at the end of the 26-week weight maintenance (WM) period (CID3). Additional three-day food diaries were collected after four weeks, and in the last week (week 26) of the WM phase. The 26-week maintenance phase was completed by 556 participants, in 489 of those data on dietary intake were also available (at week 4 (*N* = 410) or week 26 (*N* = 443) or both (*N* = 364)). These 489 subjects were included in the final analysis. For the clinical measurements the same standard operating procedures were used in all centers and all of the blood samples were analyzed in one laboratory.

2.4. Clinical Examinations, Oral Glucose Tolerance Test (OGTT) and Blood Analysis {#sec2dot4-nutrients-09-01326}
---------------------------------------------------------------------------------

Body weight, waist circumference, body composition, and blood pressure were measured, as described previously \[[@B13-nutrients-09-01326]\]. Subsequently, an OGTT was performed \[[@B13-nutrients-09-01326]\]. The Matsuda index \[[@B15-nutrients-09-01326]\], a measure of insulin sensitivity in stimulated condition derived from fasting glucose and insulin and the glucose and insulin responses during the OGTT, was calculated. From the fasting glucose and the insulin concentrations, the HOMA-IR index, a measure of fasting insulin sensitivity, was calculated as: (fasting insulin (mIU/L) × fasting glucose (mmol/L))/22.5 \[[@B16-nutrients-09-01326]\]. In fasting blood samples, plasma adiponectin concentration and serum concentrations of glucose, insulin, total cholesterol, HDL cholesterol, triglycerides, and C-reactive protein (CRP) were measured, as described previously \[[@B13-nutrients-09-01326],[@B17-nutrients-09-01326]\].

2.5. Dietary Records {#sec2dot5-nutrients-09-01326}
--------------------

All of the families were provided with household weighing scales. Dietitians instructed the subjects on how to complete the three-day food record on three consecutive days, including two weekdays and one weekend day. Participants were instructed to weigh all of their foods and left-overs and to provide brand names and details on cooking and processing where relevant. When weighing was not possible (e.g., when eating out), subjects were instructed to record food intake in household measures (cups, glasses, table spoons, etc.).

2.6. Dietary Analysis {#sec2dot6-nutrients-09-01326}
---------------------

Energy and nutrient intakes and glycemic index (GI) were calculated using national food and nutrient databases \[[@B18-nutrients-09-01326],[@B19-nutrients-09-01326],[@B20-nutrients-09-01326],[@B21-nutrients-09-01326],[@B22-nutrients-09-01326],[@B23-nutrients-09-01326]\] where these were available (UK, Denmark, The Netherlands, Germany, and Czech Republic). The UK data were used by the Spanish, Bulgarian, and Greek centres. Information from food labels, and relevant diet composition data that was provided by fast food restaurants regarding their own products were also included. Available carbohydrate is described as monosaccharide equivalents (MSE) in the UK database \[[@B19-nutrients-09-01326]\] and was therefore slightly higher compared with other databases \[[@B20-nutrients-09-01326],[@B21-nutrients-09-01326],[@B22-nutrients-09-01326],[@B23-nutrients-09-01326]\], which use available carbohydrate values. To adjust for this difference the carbohydrate values from the UK database were standardized using the formula below, where starch, monosaccharide, and disaccharide values were all available in the food composition database:

Fibre values from the UK database were adjusted for compatibility with the other food and nutrient databases. GI values were added to the tables using a procedure described in more detail elsewhere \[[@B18-nutrients-09-01326]\]. Intake of protein and GI of the diets were calculated. For the analysis of the different types of protein, all of the foods in the database were assigned to food groups. From each amount of a food consumed within a food group, the protein content (in grams) was assigned to the food group. Thus, protein intake from each food group could be determined. For protein intake, the following food groups were distinguished: (a) cereal protein intake (including protein from breads and rolls, breakfast cereals, cereal bars, flour, pasta and pasta dishes, bakery products, rice, and other cereal products); (b) non-cereal plant protein intake (including protein from nuts, pulses, vegetables, starchy roots and potatoes, fruits, non-dairy beverages); (c) red meat protein intake; (d) poultry protein intake; (e) fish protein intake; (f) dairy protein intake (including protein from milk, cheese, cream, yoghurt, ice cream and other milk products); and, (g) animal protein intake from other sources (including eggs, offal). Total plant protein intake was the combination of food groups (a) and (b), total animal protein intake was the combination of groups (c) to (g) and total meat protein as the sum of (c) and (d). If a food or dish contained a mixture of proteins from different sources, an estimation of the composition was made based on the ingredients. This was the case for 21% of protein intake at baseline and 16% and 18% during follow-up. Dietary intake during the 26-week intervention was calculated as the mean intake reported in the diaries at week 4 and week 26. If one of them was missing, then the values of the remaining diary were taken to reflect intake during the intervention.

2.7. Statistical Analysis {#sec2dot7-nutrients-09-01326}
-------------------------

Data on 489 subjects were available for analysis. Because of missing values for some of the measurements, the numbers for the different parameters may be lower. Data were analyzed by regression analysis. Dependent variables were the changes in anthropometrics, blood pressure, and metabolic parameters during the weight maintenance period. The basic model included dietary protein and fat intake (as % of total energy intake), dietary GI, and fibre intake (g/1000 kcal) as dietary factors. In addition, the type of centre, gender, BMI at randomization, and the change in the dependent variable during the weight loss (WL) phase as independent variables. This model tests the effect of replacing carbohydrate by proteins in the diet on weight regain \[[@B24-nutrients-09-01326]\]. The regression coefficient (B) gives the change in weight regain (kg) with a 1 energy % change in intake from proteins at the cost of carbohydrates. The standardized regression coefficient beta denotes the number of standard deviations that the outcome will change as a result of a one standard deviation change in the predictor. Subsequently, we tested the effect of variations in the intake of animal protein (as % of total protein intake). The results of this analysis indicate whether increasing or decreasing the animal protein intake at the cost of plant protein intake (adjusting for total protein intake) had a significant effect on the dependent variable. Additionally, we tested the effect of variations in cereal protein intake (as % of total plant protein intake, adjusting for total and animal protein intake). The result of this analysis indicates whether increasing or decreasing cereal protein intake at the cost of other plant proteins affects the dependent variable. We did similar analyses for the effects of meat protein (adjusting for total protein and animal protein intake). Statistical analyses were performed with SPSS Statistics version 20 (IBM, Armonk, NY, USA). A *p* value of \< 0.05 was considered to be statistically significant. In order to reduce the risk of false positive findings but on the other hand not to lose potentially relevant information, we set the significance level at a *p* value \< 0.010 in the regression analyses.

3. Results {#sec3-nutrients-09-01326}
==========

489 subjects were included in the analysis. Age was 42.3 ± 0.3 years (mean ± SE, standard error), BMI was 34.3 ± 0.2 kg/m^2^ and 167 subjects were male and 322 female. Further clinical characteristics are shown in [Table 1](#nutrients-09-01326-t001){ref-type="table"}. The WL phase induced significant decreases in body weight, body fat percentage, BMI, waist circumference, blood pressure, blood lipids, fasting glucose and insulin, HOMA-IR index and CRP, and significantly increased the Matsuda index. Only the adiponectin concentration did not change significantly ([Table 1](#nutrients-09-01326-t001){ref-type="table"}). During the WM phase significant increases from the end of the WL phase were found for all variables except the Matsuda index and CRP, which decreased significantly ([Table 1](#nutrients-09-01326-t001){ref-type="table"}).

Diet composition was significantly different between baseline and the WM phase ([Table 2](#nutrients-09-01326-t002){ref-type="table"}). GI was reduced and the total protein intake (as % of energy intake) was increased during the WM phase as compared with the baseline. The percentage of total protein intake from animal sources increased slightly with a proportional decrease in the intake of protein from plant sources. During WM, the proportion of cereal protein (as % of plant protein intake) and red meat protein (as % of animal protein intake) was lower than at baseline, the intakes of dairy and fish (as % of animal protein intake) were significantly higher ([Table 2](#nutrients-09-01326-t002){ref-type="table"}).

3.1. Total Protein Intake {#sec3dot1-nutrients-09-01326}
-------------------------

A higher protein intake was associated with a significantly less regain of body weight and less of an increase in the total cholesterol and fasting glucose concentration (all *p* \< 0.01) ([Table 3](#nutrients-09-01326-t003){ref-type="table"}). The increase in total cholesterol was no longer statistically significant after entering weight change over the weight maintenance period in the model, suggesting it is at least partly mediated by the weight change during the WM phase. On the other hand, the change in fasting glucose remained statistically significant after adjusting for weight change ([Table 3](#nutrients-09-01326-t003){ref-type="table"}).

3.2. Substituting Plant Proteins for Animal Proteins {#sec3dot2-nutrients-09-01326}
----------------------------------------------------

Including animal protein intake (as % of total protein intake) into the model did not significantly add to the explained variance for any of the variables studied ([Table 4](#nutrients-09-01326-t004){ref-type="table"}). This suggests that substituting plant proteins for animal proteins is not associated with beneficial effects on any of the studied variables.

3.3. Substituting Cereal Protein for Non-Cereal Plant Proteins {#sec3dot3-nutrients-09-01326}
--------------------------------------------------------------

When cereal protein intake (as % of plant protein intake) was added to the model, a higher intake of cereal protein at the cost of non-cereal plant protein, was associated with a larger increase in body weight and systolic BP (all *p* \< 0.010) ([Table 5](#nutrients-09-01326-t005){ref-type="table"}). When the change in body weight during the WM phase was included in the model, the effect on systolic BP remained statistically significant (*p* = 0.003), which suggests that it was independent of concurrent changes in body weight.

3.4. Substituting Meat Protein for Proteins from Other Animal Sources {#sec3dot4-nutrients-09-01326}
---------------------------------------------------------------------

A substitution of total meat protein intake for non-meat animal protein showed a significant positive association with the changes in fasting insulin and HOMA-IR (both *p* \< 0.010) ([Table 6](#nutrients-09-01326-t006){ref-type="table"}). Adding the weight change during the WM phase to the models did not affect this association, suggesting that the associations were not dependent on concurrent weight changes. Substituting dairy protein for non-dairy animal protein or fish protein for non-fish animal protein was not associated with statistically significant changes in any of the studied variables ([Supplemental Tables S1--S4](#app1-nutrients-09-01326){ref-type="app"}).

4. Discussion {#sec4-nutrients-09-01326}
=============

Many studies have shown that dietary protein content may play a role in weight management, with the DIOGenes trial being one of them \[[@B12-nutrients-09-01326],[@B25-nutrients-09-01326]\]. In this study, we examined the role of different sources of dietary proteins (independent of total protein intake) on the change in body weight and body composition, and on the cardiometabolic risk factors during the weight maintenance phase of the Diogenes trial. Our initial analysis confirmed the main outcome of the DIOGenes RCT (randomized controlled trial), i.e., less weight regain on a diet with higher protein content \[[@B12-nutrients-09-01326],[@B25-nutrients-09-01326]\], although we did not analyze the data according to the diet groups into which subjects were randomized, but based on self-reported dietary intake of protein. The regression model indicates that a 5% higher protein intake would be associated with approximately 0.85 kg less weight regain over six months in this study.

4.1. Animal vs. Plant Protein {#sec4dot1-nutrients-09-01326}
-----------------------------

In our study substitution of animal protein for plant protein (adjusting for total protein intake) had no significant effects on the changes in any of the studied variables. Randomized trials comparing the effects of plant and animal protein-rich diets on cardiometabolic risk factors are scarce. One trial compared modified DASH (Dietary Approaches to Stop Hypertension) diets enriched in either plant or animal protein during weight loss and weight maintenance and concluded that diet composition did not affect weight changes or metabolic syndrome criteria differently \[[@B26-nutrients-09-01326]\]. Some trials are available comparing selected plant and animal proteins. A recent study \[[@B27-nutrients-09-01326]\] explored the effect of isocaloric whey, soy, and maltodextrin supplements on weight regain after weight loss and found no significant differences. The effects of soy and whey protein provided as supplements on body weight and body composition have also been compared in free-living overweight or obese individuals without prior weight loss. The whey protein supplemented group reached a significantly lower body weight than the group that took isocaloric maltodextrin supplements, but there was no significant difference with the soy protein supplemented group after five weeks \[[@B28-nutrients-09-01326]\]. Several studies have demonstrated an inverse relationship between the intake of protein from plant sources and BP \[[@B10-nutrients-09-01326]\], although evidence from RCT's is lacking \[[@B10-nutrients-09-01326],[@B29-nutrients-09-01326]\]. Also, in these studies, it is unclear whether the effect of plant protein is independent of the effect of total protein intake. In our study we found no evidence for an association between the ratio of plant to animal protein intake and BP changes, independent of protein intake. Soy protein has been shown to have more beneficial effects on blood lipids than milk protein in healthy adults without hypercholesterolemia \[[@B30-nutrients-09-01326]\]. No clear associations have been found for animal or plant protein intake and the risk of coronary heart disease and stroke \[[@B9-nutrients-09-01326],[@B31-nutrients-09-01326],[@B32-nutrients-09-01326]\]. High intakes of animal protein, but not plant protein, have been associated with an increased diabetes risk \[[@B11-nutrients-09-01326],[@B33-nutrients-09-01326],[@B34-nutrients-09-01326]\]. A similar association was found for total protein intake \[[@B11-nutrients-09-01326],[@B34-nutrients-09-01326]\]. In our study, we found no indications that substituting plant protein for animal protein would have an effect on the change in glucose homeostasis. An analysis of data from the Nurses Health Study showed that substituting plant protein for animal protein reduced cardiovascular mortality, especially when red meat was replaced, in individuals with at least one unhealthy lifestyle factor, including obesity \[[@B35-nutrients-09-01326]\].

4.2. Substituting Cereal for Non-Cereal Plant Proteins {#sec4dot2-nutrients-09-01326}
------------------------------------------------------

A higher cereal protein intake, without changes in total plant and animal protein intake, was associated with unfavorable effects on body weight gain and changes in systolic blood pressure in our study population. This suggests that replacing cereal protein by an equal amount of non-cereal plant protein, e.g., from pulses, vegetables, nuts, fruits, and potatoes, may have beneficial effects on weight regain and associated changes in those cardiometabolic risk factors. A meta-analysis of randomized controlled trials comparing diets in which whole pulses were exchanged for other dietary components showed that dietary pulses lead to modest weight loss. Pulses may therefore explain (part of) this effect \[[@B36-nutrients-09-01326]\]. In addition, evidence suggests that the consumption of refined grains is associated with weight gain \[[@B37-nutrients-09-01326]\]. It is unclear whether the effects are related to differences in the protein or amino acid composition of the protein fractions of cereal and non-cereal foods or to differences in other aspects of these foods, such as the presence of bioactive compounds, which may affect satiety or energy expenditure. So far, no studies have directly compared the exchange between cereal and non-cereal protein, or cereal and non-cereal foods. Differences in GI and fiber are unlikely to play a role, because these factors were included in the model.

4.3. Substituting Meat for Other Animal Proteins {#sec4dot3-nutrients-09-01326}
------------------------------------------------

As discussed by Comerford and Pasin, animal proteins from different sources have different qualities \[[@B38-nutrients-09-01326]\], which complicate the research, because all of the possible combinations of types of animal proteins, even within groups such as dairy, fish, and meat, should ideally be taken into account. In this study, we found that higher consumption of meat instead of other animal proteins, such as dairy, fish, and eggs, did not affect weight regain but was associated with a larger increase in fasting insulin and HOMA-IR during the weight maintenance phase. Which dietary factor(s) is responsible for these associations is not clear. When we investigated substituting red meat, poultry, fish, and dairy for other animal proteins separately, we did not find significant associations with the increase in fasting insulin and HOMA-IR ([Supplementary Tables S1--S4](#app1-nutrients-09-01326){ref-type="app"}). Red meat consumption has been associated with the risk of type 2 diabetes, but this association appears to be mainly due to processed red meat consumption, and is therefore most likely related to non-protein factors \[[@B33-nutrients-09-01326]\]. In randomized diet interventions in overweight adults comparing beef or chicken as the primary protein source, no differences in body weight or fat loss were found \[[@B39-nutrients-09-01326],[@B40-nutrients-09-01326],[@B41-nutrients-09-01326]\].

The study reported here has certain limitations that need to be acknowledged. Although the DIOGenes trial was a randomized controlled trial, for the analysis reported here the results were analyzed as an observational study. Therefore, the strengths of the original RCT study design have been lost. On the other hand, this analysis allowed us to take variations in more dietary factors than the main factors in the DIOGenes trial (protein intake and GI) into account in a considerable number of subjects with a large number of clinical measurements. A weak point in all of the dietary analysis studies is that we have to rely on self-reported data of which the quality is known to be a problem. Although our analyses focused on the protein intake from various food groups, the interpretation of the results is complicated since we cannot exclude that it is not the protein intake from certain sources, but rather the complete foods from these sources that are responsible for the effects that were found. Misclassification of protein sources also cannot be ruled out, especially for foods with mixed proteins, which comprised 16--21% of protein intake. Although we adjusted for a number of the most important interfering factors (such as fibre, fat, and GI), residual confounding cannot be excluded. In addition, we cannot rule out that the associations are confounded by other lifestyle factors, such as physical activity, impaired or less sleep, stress, socioeconomic status, and education.

5. Conclusions {#sec5-nutrients-09-01326}
==============

In summary, we found no indications that a higher plant protein intake with a proportional decrease in animal protein intake affects body weight maintenance after weight loss or changes in cardiometabolic risk factors during this period. A higher plant protein intake from non-cereal products was associated with benefits for body weight maintenance and systolic blood pressure. Meat protein consumption instead of protein from other animal sources was associated with increases in fasting insulin and HOMA-IR. This analysis therefore suggests that not only the amount of dietary proteins, but also the source, may be important in weight and cardiometabolic risk management. However, randomized trials are needed to test whether these associations are indeed causal.

The DIOGenes trial was funded by the European Commission, contract No. FP6-2005-513946. The funding source had no role in the study design, data collection, data analysis, data interpretation or writing of the report. The majority of the food items in the shops were provided for free by a large number of different food companies. A complete list can be found on [www.diogenes-eu.org](www.diogenes-eu.org). Food items to be offered in the shops were selected by the investigators. Companies were in no way involved in the planning, execution or analysis of the study. We would like to acknowledge the input of Stephen Whybrow and Marielle Engberink in preparing the food database for this analysis.

The following are available online at [www.mdpi.com/2072-6643/9/12/1326/s1](www.mdpi.com/2072-6643/9/12/1326/s1), Table S1: Regression coefficients for the associations between changes in anthropometric variables, blood pressure and metabolic factors during the weight maintenance phase and red meat protein intake; Table S2: Regression coefficients for the associations between changes in anthropometric variables, blood pressure and metabolic factors during the weight maintenance phase and dairy protein intake; Table S3: Regression coefficients for the associations between changes in anthropometric variables, blood pressure and metabolic factors during the weight maintenance phase and poultry protein intake; Table S4: Regression coefficients for the associations between changes in anthropometric variables, blood pressure and metabolic factors during the weight maintenance phase and fish protein intake.

###### 

Click here for additional data file.
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nutrients-09-01326-t001_Table 1

###### 

Characteristics of the participants at the three clinical investigation days (CID1 = baseline; CID2 = end of weight loss phase; CID = end of weight maintenance phase) ^1^.

  Variable ^2^                CID1           CID2          CID3           *p* Value ^3^   *p* Value ^4^
  --------------------------- -------------- ------------- -------------- --------------- ---------------
  Body weight (kg)            99.5 ± 0.8     88.3 ± 0.7    88.8 ± 0.7     \<0.001         0.031
  Body fat (%)                40.3 ± 0.4     36.2 ± 0.5    35.2 ± 0.4     \<0.001         \<0.001
  BMI (kg/m^2^)               34.3 ± 0.2     30.5 ± 0.2    30.6 ± 0.2     \<0.001         0.039
  Waist circumference (cm)    107.4 ± 0.6    97.1 ± 0.6    97.7 ± 0.6     \<0.001         0.048
  SBP (mm Hg)                 125.4 ± 0.7    117.5 ± 0.6   122.2 ± 0.6    \<0.001         \<0.001
  DBP (mm Hg)                 77.6 ± 0.5     72.3 ± 0.4    74.5 ± 0.5     \<0.001         \<0.001
  Totalcholesterol (mmol/L)   4.85 ± 0.05    4.15 ± 0.04   4.90 ± 0.04    \<0.001         \<0.001
  HDL cholesterol (mmol/L)    1.23 ± 0.02    1.15 ± 0.01   1.38 ± 0.02    \<0.001         \<0.001
  LDL cholesterol (mmol/L)    3.01 ± 0.04    2.52 ± 0.04   2.98 ± 0.04    \<0.001         \<0.001
  Glucose (mmol/L)            5.09 ± 0.03    4.80 ± 0.02   4.93 ± 0.02    \<0.001         \<0.001
  Insulin (mIU/L)             12.42 ± 0.59   8.33 ± 0.49   9.49 ± 0.50    \<0.001         0.001
  HOMA IR index               3.36 ± 0.17    2.13 ± 0.14   2.50 ± 0.14    \<0.001         0.001
  Matsuda index               4.87 ± 0.15    7.23 ± 0.19   6.80 ± 0.19    \<0.001         0.011
  CRP (mg/L)                  3.65 ± 0.15    2.65 ± 0.12   2.37 ± 0.11    \<0.001         0.009
  Adiponectin (mg/L)          9.18 ± 0.20    9.38 ± 0.18   10.87 ± 0.21   0.230           \<0.001

^1^ Values are mean ± SEM, (Standard Error of Mean); ^2^ Repeated measures ANOVA (CID1 vs. CID2 vs. CID3) *p* \< 0.001 for all variables; ^3^ *p* value of post-hoc comparison CID1 vs. CID2; ^4^ *p* value of post-hoc comparison CID2 vs. CID3. SBP: systolic blood pressure. DBP: diastolic blood pressure.

nutrients-09-01326-t002_Table 2

###### 

Dietary intakes at baseline during the weight maintenance phase ^1^.

  Variable                                                   Baseline      Weight Maintenance   *p* Value ^2^
  ---------------------------------------------------------- ------------- -------------------- ---------------
  Energy intake (kJ/day)                                     9380 ± 143    6668 ± 101           \<0.001
  Total protein intake (% energy)                            16.9 ± 0.2    19.9 ± 0.2           \<0.001
  GI (GI units)                                              61.1 ± 0.2    58.5 ± 0.2           \<0.001
  CHO intake (% energy)                                      44.6 ± 0.4    48.1 ± 0.4           \<0.001
  Fat intake (% energy)                                      36.2 ± 0.3    30.5 ± 0.3           \<0.001
  Fiber intake (g/1000 kJ)                                   2.14 ± 0.04   3.12 ± 0.05          \<0.001
  Animal protein intake (% of total protein intake)          61.2 ± 0.6    62.3 ± 0.6           0.036
  Plant protein intake (% of total protein intake)           38.8 ± 0.6    37.7 ± 0.6           0.035
  Cereal protein intake (% of plant protein intake)          68.9 ± 0.9    61.3 ± 0.8           \<0.001
  Red meat protein intake (% of animal protein intake)       37.0 ± 1.0    28.0 ± 0.9           \<0.001
  Dairy protein intake (% of animal protein intake)          31.1 ± 0.8    34.0 ± 0.8           0.003
  Poultry meat protein intake (% of animal protein intake)   12.7 ± 0.8    14.8 ± 0.6           0.092
  Fish protein intake (% of animal protein intake)           8.1 ± 0.6     14.0 ± 0.7           \<0.001

^1^ Values are mean ± SEM; ^2^ *p* value of difference between baseline and weight maintenance. CHO: Carbohydrate.

nutrients-09-01326-t003_Table 3

###### 

Regression coefficients (B), their standard error (SE) and the standardized regression coefficients (Beta) for the associations between changes in anthropometric variables, blood pressure and metabolic factors during the weight maintenance phase and total protein intake (% of energy intake) ^1^.

  Variable                     B        SE      Beta     *p* Value
  ---------------------------- -------- ------- -------- --------------
  Body weight (kg)             −0.169   0.053   −0.142   **0.001**
  Body fat (%)                 −0.076   0.049   −0.084   0.120
  Waist circumference (cm)     −0.027   0.065   −0.019   0.676
  Systolic BP (mm Hg)          −0.178   0.114   −0.066   0.120
  Diastolic BP (mm Hg)         −0.136   0.076   −0.078   0.074
  Total cholesterol (mmol/L)   −0.018   0.007   −0.109   **0.005**
  HDL cholesterol (mmol/L)     −0.004   0.002   −0.084   0.050
  LDL cholesterol (mmol/L)     −0.011   0.006   −0.078   0.045
  Triglycerides (mmol/L)       −0.009   0.004   −0.091   0.031
  Fasting glucose (mmol/L)     −0.014   0.004   −0.136   **0.001 \***
  Fasting insulin (mIU/L)      −0.132   0.072   −0.098   0.069
  HOMA-IR                      −0.037   0.023   −0.080   0.107
  Matsuda index                0.035    0.030   0.052    0.245
  CRP (mg/L)                   −0.005   0.021   −0.010   0.826
  Adiponectin (mg/L)           −0.033   0.034   −0.040   0.327

^1^ Regression models also included BMI at randomization, changes in the dependent variables during the weight loss phase, gender, type of centre, GI, dietary fat intake (as % of energy intake) and fibre intake (g/1000 kcal); \* remains significant after adjusting for weight change during WM.

nutrients-09-01326-t004_Table 4

###### 

Regression coefficients (B), their standard error (SE) and the standardized regression coefficients (Beta) for the associations between changes in anthropometric variables, blood pressure and metabolic factors during the weight maintenance phase and animal protein intake (% of total protein intake) ^1^.

  Variable                     B        SE      Beta     *p* Value
  ---------------------------- -------- ------- -------- -----------
  Body weight (kg)             0.040    0.032   0.086    0.213
  Body fat (%)                 0.075    0.029   0.216    0.011
  Waist circumference (cm)     0.040    0.041   0.073    0.321
  Systolic BP (mm Hg)          −0.012   0.070   −0.011   0.866
  Diastolic BP (mm Hg)         0.081    0.046   0.121    0.081
  Total cholesterol (mmol/L)   0.008    0.004   0.126    0.043
  HDL cholesterol (mmol/L)     0.000    0.001   0.021    0.766
  LDL cholesterol (mmol/L)     0.008    0.003   0.142    0.021
  Triglycerides (mmol/L)       −0.001   0.003   −0.021   0.759
  Fasting glucose (mmol/L)     0.000    0.003   0.006    0.933
  Fasting insulin (mIU/L)      0.004    0.046   0.007    0.939
  HOMA-IR                      0.002    0.015   0.010    0.898
  Matsuda index                −0.005   0.019   −0.019   0.790
  CRP (mg/L)                   −0.013   0.013   −0.069   0.335
  Adiponectin (mg/L)           −0.035   0.021   −0.112   0.088

^1^ Regression models also included BMI at randomization, changes in the dependent variables during the weight loss phase, gender, type of centre, dietary protein intake (as % of energy intake), GI, dietary fat intake (as % of energy intake) and fibre intake (g/1000 kcal).

nutrients-09-01326-t005_Table 5

###### 

Regression coefficients (B), their standard error (SE) and the standardized regression coefficients (Beta) for the associations between cereal protein intake (% of total plant protein intake) and changes in anthropometric variables, blood pressure and metabolic factors during the weight maintenance phase ^1^.

  Variable                     B        SE      Beta     *p* Value
  ---------------------------- -------- ------- -------- --------------
  Body weight (kg)             0.045    0.014   0.150    0.001
  Body fat (%)                 0.031    0.013   0.146    0.014
  Waist circumference (cm)     0.045    0.017   0.127    0.011
  Systolic BP (mm Hg)          0.113    0.030   0.166    **0.000 \***
  Diastolic BP (mm Hg)         0.040    0.020   0.092    0.049
  Total cholesterol (mmol/L)   −0.001   0.002   −0.030   0.475
  HDL cholesterol (mmol/L)     0.000    0.001   −0.016   0.731
  LDL cholesterol (mmol/L)     −0.002   0.002   −0.062   0.143
  Triglycerides (mmol/L)       0.003    0.001   0.108    0.018
  Fasting glucose (mmol/L)     0.001    0.001   0.040    0.389
  Fasting insulin (mIU/L)      −0.022   0.020   −0.065   0.267
  HOMA-IR                      −0.005   0.006   −0.048   0.380
  Matsuda index                0.003    0.008   0.016    0.745
  CRP (mg/L)                   −0.012   0.006   −0.106   0.032
  Adiponectin (mg/L)           −0.018   0.009   −0.090   0.046

^1^ Regression models also included BMI at randomization, changes in the dependent variables during the weight loss phase, gender, type of centre, dietary protein intake (as % of energy intake), animal protein intake (as % of total protein intake), GI, dietary fat intake (as % of energy intake) and fibre intake (g/1000 kcal); \* remains significant after adjusting for weight change during WM. LDL: low density lipoprotein.

nutrients-09-01326-t006_Table 6

###### 

Regression coefficients (B), their standard error (SE) and the standardized regression coefficients (Beta) for the associations between changes in anthropometric variables, blood pressure, and metabolic factors during the weight maintenance phase and total meat protein intake ^1^.

  Variable                     B        SE      Beta     *p* Value
  ---------------------------- -------- ------- -------- --------------
  Body weight (kg)             0.023    0.014   0.073    0.105
  Body fat (%)                 0.015    0.013   0.065    0.260
  Waist circumference (cm)     0.015    0.017   0.042    0.382
  Systolic BP (mm Hg)          −0.035   0.030   −0.050   0.247
  Diastolic BP (mm Hg)         −0.035   0.020   −0.079   0.081
  Total cholesterol (mmol/L)   0.001    0.002   0.021    0.596
  HDL cholesterol (mmol/L)     0.000    0.001   −0.005   0.908
  LDL cholesterol (mmol/L)     0.001    0.001   0.026    0.512
  Triglycerides (mmol/L)       0.000    0.001   −0.001   0.980
  Fasting glucose (mmol/L)     0.001    0.001   0.029    0.507
  Fasting insulin (mIU/L)      0.064    0.019   0.178    **0.001 \***
  HOMA-IR                      0.017    0.006   0.138    **0.006 \***
  Matsuda index                −0.010   0.008   −0.057   0.207
  CRP (mg/L)                   −0.007   0.006   −0.059   0.201
  Adiponectin (mg/L)           0.012    0.009   0.056    0.185

^1^ Regression models also included BMI at randomization, changes in the dependent variables during the weight loss phase, gender, type of centre, dietary protein intake (as % of energy intake), animal protein intake (as % of total protein intake), GI, dietary fat intake (as % of energy intake) and fibre intake (g/1000 kcal); \* remains significant after adjusting for weight change during WM.
